Results 71 to 80 of about 55,628 (162)

Effects of atorvastatin on inflammatory markers, lipid profile, liver enzymes, and pulmonary function in patients with lung diseases: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Eur J Med Res
Baseri S, Izadi M, Alimohammadi M, Khoshnazar SM, Nikdel R, Hushmandi K.   +5 more
europepmc   +1 more source

Diagnostic and prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study

Swiss Medical Weekly, 2009
M Gruber
doaj   +1 more source

Exploratory analysis of exhaled volatile organic compounds for binary discrimination between lung cancer, pneumonia, and healthy controls using machine learning. [PDF]

Front Med (Lausanne)
Wang J, Li H, Yue J, Song Y, Wang N, Guo W, Cai Z.   +6 more
europepmc   +1 more source

Repurposing loratadine to reverse colistin resistance in <i>Klebsiella pneumoniae</i> through targeting lipid A modification. [PDF]

Emerg Microbes Infect
Wu X, Ge Z, Zhan H, Zheng M, Feng Y, Zhai Y, Yuan L, Liu J, Pan Y, Hu G, Ma X, He D.   +11 more
europepmc   +1 more source

Resistance, heteroresistance, and fitness costs drive colistin treatment failure during <i>Acinetobacter baumannii</i> pneumonia. [PDF]

Proc Natl Acad Sci U S A
Hernandez-Bird J, He B, VanOtterloo LM, Billings EB, Huo W, Teodoro GIC, Echlin H, Rosch JM, Trent MS, Isberg RR.   +9 more
europepmc   +1 more source

Associations between parenteral energy or amino acid doses and clinical outcomes in fasting patients undergoing gastroenterological cancer surgery: a nationwide cohort study using real-world data. [PDF]

Gastroenterol Rep (Oxf)
Kawaguchi Y, Murotani K, Hayashi N, Kamoshita S.   +3 more
europepmc   +1 more source

Fatal lipid pneumonia and liquid paraffin

International Journal of Clinical Practice, 1990
openaire   +2 more sources

Toxic interstitial lung disease in cattle. [PDF]

J Vet Diagn Invest
Barros CSL, Riet-Correa F, Mendes RE, Rissi DR.   +3 more
europepmc   +1 more source

Antimicrobial peptide delivery to lung as peptibody mRNA in anti-inflammatory lipids treats multidrug-resistant bacterial pneumonia. [PDF]

Nat Biotechnol
Xue Y, Hou X, Wang S, Zhang Y, Zhong Y, Kang DD, Wang C, Li H, Yu C, Liu Z, Tian M, Cao D, Zheng YY, Deng B, Hamon P, Merad M, Dong Y.   +16 more
europepmc   +1 more source

[Lipid pneumonia].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1979
openaire   +1 more source